[1]. Basco LK, et al. In vitro activity of pyrimethamine, cycloguanil, and other antimalarial drugs against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg. 1994 Feb; 50(2):193-9.
[2]. Inceboz T, et al. Preparation of (131)I-Pyrimethamine and evaluation for scintigraphy of experimentally Toxoplasma gondii-infectedrats. J Drug Target. 2013 Feb;21(2):175-9.
[3]. Wright PD, et al. Screening for inhibitors of the SOD1 gene promoter: pyrimethamine does not reduce SOD1 levels in cell and animal models. Neurosci Lett. 2010 Oct 4;482(3):188-92.
[4]. Martins-Duarte ES, et al. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model. Exp Parasitol. 2013 Mar;133(3):294-9.
[5]. Taylor WR, et al. Antimalarial drug toxicity: a review. Drug Saf. 2004;27(1):25-61.
五、分子性质数据:
1、 摩尔折射率:69.94
2、 摩尔体积(m3/mol):190.4
3、 等张比容(90.2K):533.0
4、 表面张力(dyne/cm):61.3
5、 极化率(10 -24cm 3):27.72
1.疏水参数计算参考值(XlogP):无
2.氢键供体数量:2
3.氢键受体数量:4
4.可旋转化学键数量:2
5.互变异构体数量:17
6.拓扑分子极性表面积77.8
7.重原子数量:17
8.表面电荷:0
9.复杂度:243
10.同位素原子数量:0
11.确定原子立构中心数量:0
12.不确定原子立构中心数量:0
13.确定化学键立构中心数量:0
14.不确定化学键立构中心数量:0
15.共价键单元数量:1
武汉东康源科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!